The Sycophancy Problem in AI
Explore the challenges of AI prioritizing helpfulness over accuracy, especially in medicine. Discover how researchers are addressing these issues and what it means for the future of AI.
Seniors at Risk with Supplements
Many seniors mix supplements with medications, not knowing the risks. It’s crucial for them to discuss all their treatments with healthcare providers to avoid harmful interactions.
From AI Dream to Mental Health Crisis
When Etienne Brisson, a Quebecois business coach, learned from a family member that he had created the world’s first sentient AI, he was intrigued. However, his fascination quickly spiraled into a nightmare.
WeCanReason Speakers’ Weekly Update
Catch up with what our speakers did last week
No More Stray Signals
The Square Kilometre Array is almost ready, with new Faraday cages ensuring clear signals from the universe. Discover how this technology will enhance our understanding of the cosmos.
See what leaders in science, secularism, critical thinking, and skepticism did last week
Here's a little of what secularists, skeptics, atheists, and scientists did last week
Steel’s Surprising Future
Discover how recent findings in steel manufacturing could revolutionize material science and lead to new applications in technology.
Navigating Truth Online: Join Media Literacy Week
Media Literacy Week 2025, hosted by MediaSmarts, helps Canadians navigate misinformation, AI, and online safety through national events, workshops, and activities from October 27–31, with Digital Citizen Day on October 29 promoting responsible digital engagement.
WeCanReason Webinar – Ghost hunting for skeptics with Jon Michael
In this presentation, Jon will go over his journey from ghost hunter to skeptic. He will discuss the history of ghost hunting, bring us up to speed on the state of ghost hunting today, and delve into the mind of a believer in relation to the paranormal.
New Hope for Neurodegenerative Diseases
A new FDA-approved gene therapy delivery platform offers hope for treating rare retinal disorders and could lead to breakthroughs for neurodegenerative diseases. This innovation in gene therapy is set to transform medical treatment options.







